Why Pfizer's 2017 Was Mediocre at Best Post author:Sam Post published:December 12, 2017 Post category:BioPharma Pfizer’s 2017 wasn’t horrible. Just ho-hum. Source: BioSpace You Might Also Like ProQR Therapeutics B.V. Announces Results For The Fourth Quarter And Full Year 2016 And Provides A Business Update February 27, 2017 Synthorx Appoints As Senior Vice President Of Research August 13, 2017 Oxford Immunotec Schedules First Quarter 2017 Earnings Release And Conference Call For May 2, 2017 April 19, 2017
ProQR Therapeutics B.V. Announces Results For The Fourth Quarter And Full Year 2016 And Provides A Business Update February 27, 2017
Oxford Immunotec Schedules First Quarter 2017 Earnings Release And Conference Call For May 2, 2017 April 19, 2017
